Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Surmodics Inc (SRDX)

Surmodics Inc (SRDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 463,307
  • Shares Outstanding, K 14,260
  • Annual Sales, $ 132,580 K
  • Annual Income, $ -1,540 K
  • 60-Month Beta 1.04
  • Price/Sales 3.72
  • Price/Cash Flow 44.06
  • Price/Book 3.97
Trade SRDX with:

Options Overview Details

View History
  • Implied Volatility 50.30% ( +16.17%)
  • Historical Volatility 84.97%
  • IV Percentile 18%
  • IV Rank 36.69%
  • IV High 78.20% on 10/30/23
  • IV Low 34.13% on 05/02/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 29
  • Volume Avg (30-Day) 19
  • Put/Call OI Ratio 2.59
  • Today's Open Interest 230
  • Open Int (30-Day) 119

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.29
  • Number of Estimates 2
  • High Estimate -0.29
  • Low Estimate -0.29
  • Prior Year 0.52
  • Growth Rate Est. (year over year) -155.77%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.17 +29.08%
on 04/30/24
35.50 -8.48%
on 05/02/24
+5.53 (+20.51%)
since 04/03/24
3-Month
25.17 +29.08%
on 04/30/24
35.50 -8.48%
on 05/02/24
+0.72 (+2.27%)
since 02/02/24
52-Week
16.79 +93.51%
on 05/25/23
39.41 -17.56%
on 09/11/23
+9.47 (+41.14%)
since 05/03/23

Most Recent Stories

More News
SurModics: Fiscal Q2 Earnings Snapshot

SurModics: Fiscal Q2 Earnings Snapshot

SRDX : 32.49 (-5.96%)
SurModics: Fiscal Q1 Earnings Snapshot

SurModics: Fiscal Q1 Earnings Snapshot

SRDX : 32.49 (-5.96%)
SurModics: Fiscal Q4 Earnings Snapshot

SurModics: Fiscal Q4 Earnings Snapshot

SRDX : 32.49 (-5.96%)
SurModics: Fiscal Q3 Earnings Snapshot

SurModics: Fiscal Q3 Earnings Snapshot

SRDX : 32.49 (-5.96%)
Why Shares of Surmodics Jumped This Week

The company gained FDA marketing approval for a drug-coated balloon that will help clear blocked arteries.

SRDX : 32.49 (-5.96%)
Why Shares of Surmodics Soared on Tuesday

An analyst upgrade gave the stock a boost.

SRDX : 32.49 (-5.96%)
Surmodics (SRDX) Q2 Earnings Top Estimates, FY23 View Revised

Surmodics (SRDX) reports a solid fiscal second-quarter top line on the back of robust Medical Device revenues.

JNJ : 149.27 (-0.43%)
ISRG : 381.36 (+0.98%)
EW : 85.25 (+0.22%)
SRDX : 32.49 (-5.96%)
SurModics (SRDX) Reports Q2 Loss, Tops Revenue Estimates

SurModics (SRDX) delivered earnings and revenue surprises of 18.37% and 4.63%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

SRDX : 32.49 (-5.96%)
PODD : 174.43 (+0.58%)
SurModics: Fiscal Q2 Earnings Snapshot

SurModics: Fiscal Q2 Earnings Snapshot

SRDX : 32.49 (-5.96%)
Surmodics Reports Second Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its second quarter ended March...

SRDX : 32.49 (-5.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.'The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable...

See More

Key Turning Points

3rd Resistance Point 37.23
2nd Resistance Point 36.22
1st Resistance Point 34.35
Last Price 32.49
1st Support Level 31.48
2nd Support Level 30.47
3rd Support Level 28.61

See More

52-Week High 39.41
Last Price 32.49
Fibonacci 61.8% 30.77
Fibonacci 50% 28.10
Fibonacci 38.2% 25.43
52-Week Low 16.79

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar